Skip to main content

Avalon GloboCare Corp. (AVCO)

NASDAQ: AVCO · Delayed Price · USD
0.970 0.010 (1.03%)
Sep 24, 2021 4:00 PM EDT - Market closed
Market Cap82.07M
Revenue (ttm)1.35M
Net Income (ttm)-11.08M
Shares Out85.41M
EPS (ttm)-0.13
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume65,694
Open0.950
Previous Close0.960
Day's Range0.940 - 0.970
52-Week Range0.803 - 1.650
Beta0.36
Analystsn/a
Price Targetn/a
Est. Earnings DateNov 9, 2021

About AVCO

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. It also develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, c...

IndustryHealth Care Providers & Services
Employees6
Stock ExchangeNASDAQ
Ticker SymbolAVCO
Full Company Profile

Financial Performance

In 2020, AVCO's revenue was $1.38 million, a decrease of -10.90% compared to the previous year's $1.55 million. Losses were -$12.68 million, -29.83% less than in 2019.

Financial Statements

News

AVALON GLOBOCARE INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Aval...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Hebei Senlang Biot...

2 weeks ago - Business Wire

UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCare

PITTSBURGH, Aug. 04, 2021 (GLOBE NEWSWIRE) -- A new collaboration among UPMC Hillman Cancer Center, the University of Pittsburgh and New Jersey-based biotechnology company Avalon GloboCare Corp. (NASDAQ...

1 month ago - GlobeNewsWire

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Avalon GloboCare Corp. - AVCO

NEW YORK, July 16, 2021 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Actio...

2 months ago - PRNewsWire

Avalon GloboCare Announces its Planned Acquisition Target, SenlangBio, has Initiated First-In-Human Clinical Trial in...

Trial evaluating EphA2-targeted CAR T-cell therapy in recurrent glioblastoma, an urgent and significant unmet medical need with no standard of care treatment option

2 months ago - GlobeNewsWire

Avalon GloboCare CEO Provides Letter to Update Shareholders About Acquisition of SenlangBio

Previously Announced Execution of Definitive Agreement to Acquire SenlangBio

2 months ago - GlobeNewsWire

INVESTIGATION ALERT: Halper Sadeh LLP Investigates FBNC, AVCO, XEC, CLDR, SBBP; Shareholders are Encouraged to Contac...

NEW YORK, June 15, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: First Bancorp (NASDAQ: FBNC)  concerning potential vio...

Other symbols:CLDRFBNCSBBPXEC
3 months ago - PRNewsWire

Avalon Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Avalon GloboCare Cor...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Avalon GloboCare Corp. (NASDAQ: AVCO) and Hebei Senlang Biotechnology Co. Ltd is fa...

3 months ago - Business Wire

Avalon GloboCare Adds Cell Therapy-Based Candidates For Cancer With SenlangBio Acquisition: Highlights

Avalon GloboCare Corp (NASDAQ: AVCO) has agreed to acquire Hebei Senlang Biotechnology, dubbed SenlangBio, a China-based cell therapy company, in an all-stock transaction. In connection with the transac...

3 months ago - Benzinga

Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction

SenlangBio, a world-class cell therapy company, has developed a robust pipeline which includes 15 autologous and universal (“off-the-shelf”) CAR-T and CAR-γδ T cell therapy candidates targeting hematolo...

3 months ago - GlobeNewsWire

Avalon GloboCare to Present at the Noble Capital Markets Investor Forum During the 16th Annual World Stem Cell Summit...

FREEHOLD, N.J., June 11, 2021 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today anno...

3 months ago - GlobeNewsWire

Avalon GloboCare To Present Its S-Layer and QTY Code Breakthrough Technology Platforms at The Prestigious Annual Worl...

FREEHOLD, N.J., June 08, 2021 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today anno...

3 months ago - GlobeNewsWire

Avalon GloboCare is seeking to tap the power of cells to fight cancer and coronavirus

Specializes in developing cell-based technologies and manages stem-cell banks and clinical laboratories Creates proprietary diagnostic and therapeutic products leveraging regenerative medicine and exoso...

5 months ago - Proactive Investors

Avalon GloboCare to partner with University of Pittsburgh Medical Center Hillman Cancer Center to develop therapies u...

Avalon GloboCare Corp (NASDAQ:AVCO) said it will collaborate with the University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center to advance the company's AVA-011 therapy and other RNA-based ca...

5 months ago - Proactive Investors

Avalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center to Ad...

FREEHOLD, N.J., March 29, 2021 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today ann...

5 months ago - GlobeNewsWire

Avalon GloboCare expands its MIT co-development research program to fight cancer spread

Avalon GloboCare Corp (NASDAQ:AVCO) has said it is expanding its co-development research program with the Massachusetts Institute of Technology (MIT), involving the use of CRISPR-based genome editing an...

6 months ago - Proactive Investors

Avalon GloboCare Expands Co-Development Program with MIT to Combat Cancer Metastasis

FREEHOLD, N.J., March 22, 2021 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today ann...

6 months ago - GlobeNewsWire

Avalon GloboCare seeking to tap the power of cells to fight cancer and coronavirus

Specializes in developing cell-based technologies and manages stem-cell banks and clinical laboratories Creates proprietary diagnostic and therapeutic products leveraging regenerative medicine and exoso...

6 months ago - Proactive Investors

Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand Partnership and Accelerate Devel...

FREEHOLD, N.J., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today anno...

8 months ago - GlobeNewsWire

Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point...

Assure/Fastep® COVID-19 Point-of-Care Antibody Test is the First Test Granted FDA Emergency Use Authorization for Use with Fingerstick Blood Samples Assure/Fastep® COVID-19 Point-of-Care Antibody Test i...

11 months ago - GlobeNewsWire

Avalon GloboCare Provides Clinical Updates on Its CAR-T Immuno-Oncology and Allogeneic Mesenchymal Stromal Cell (MSC)...

FREEHOLD, N.J., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, today provided a clinical update o...

11 months ago - GlobeNewsWire

Avalon GloboCare CEO to Participate in Virtual Panel: “New Approaches to COVID-19: Hidden Breakthroughs,” on Thursday...

FREEHOLD, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today a...

1 year ago - GlobeNewsWire

Avalon GloboCare Announces Mesenchymal Stromal Cell Therapeutic Platform for COVID-19 and Acute Graft Versus Host Dis...

FREEHOLD, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today a...

1 year ago - GlobeNewsWire

Avalon GloboCare Announces Commercialization and Distribution Agreement with Cellex for COVID-19 Antibody Rapid Test Kit

In anticipation of high demand, Avalon is working with Cellex to source manufacturing facilities and develop next generation COVID-19 testing kits In anticipation of high demand, Avalon is working with ...

1 year ago - GlobeNewsWire

Avalon GloboCare Expands AVA-Trap™ Program to Treat COVID-19 and CAR-T Related Cytokine Storms

FREEHOLD, N.J., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, announce...

1 year ago - GlobeNewsWire

Avalon GloboCare Provides Updates on its Lead Scientific and Clinical Programs in CAR T-Cell Therapy and COVID-19

FREEHOLD, N.J., July 13, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, today announced an update on its...

1 year ago - GlobeNewsWire